TY - JOUR T1 - Endometrium receptivity and the dose-related effects of Acupuncture therapies in infertile women: a protocol for systematic review and meta analysis JF - medRxiv DO - 10.1101/2021.04.02.21254309 SP - 2021.04.02.21254309 AU - Xiaoyan Zheng AU - Liying Liu AU - Hang Zhou AU - Hongmei Yang AU - Fangge Wang AU - Jie Yang Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/07/2021.04.02.21254309.abstract N2 - Introduction The aim of the systematic review (SR) is to evaluate the efficacy of Acupuncture in endometrium receptivity(ER) of infertile women and find out dose-related between Acupuncture and ER improving.Methods and analysis We will search four English databases: PubMed, Embase, Cochrane Library, Web of Science, and five Chinese databases: SinoMed (formerly Chinese Biomedical Database), CNKI (Chinese National Knowledge Infrastructure), Wanfang Data, and China Biomedical Literature Database (CBM), China Science Journal Database (VIP database) from inception to February 2021 in English and Chinese. Also, we will manually retrieve other resources, including reference lists of identified publications, conference articles, and grey literature. All clinical randomized controlled trials related to Acupuncture for endometrium receptivity of infertile women will be included. Two review authors will perform all research selection, data extraction, and research quality assessment. According to suggestions, data will be synthesized in a fixed-effect model, or random effect model due to the heterogeneity test. The primary outcomes include ER (endometrial thickness and endometrial hemodynamic parameters) and clinical pregnancy rate(CPR). Secondary outcomes include a dose of the interventions(the starting time of Acupuncture, the duration, and frequency of Acupuncture sessions), and adverse events will be assessed. We will use the statistical package (RevMan5.4.0) provided by The Cochrane Collaboration to analyze data. The quality of evidence will be assessed by using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework.Ethics and dissemination Since this article does not contain patient personal information, ethical approval is not required. The contract is distributed by a peer-reviewSystematic review registration PROSPERO, CRD42020206790Strengths and limitations of this study This study will be the first ever systematic review and meta-analysis in dose-related effects of Acupuncture therapies in treating endometrium receptivity.The quality of evidence will be assessed by the Grading of Recommendations Assessment,Development, and Evaluation system.Our research approach will only focus on the dosage of acupuncture interventions. Due to the diversity of included treatment plans, Traditional Chinese Medicine and Moxibustion will increase the heterogeneity of results.We will only retrieve data from Chinese and English databases which could limit available data or result in language bias.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPROSPERO, CRD42020206790Funding StatementThis study is funded by a program of the National Natural Science Foundation of China(fund no: 8197152387)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval is required because the study is based on published data. The results of this systematic review will be disseminated through peer-reviewed publications.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used or analysed during the current study are available from the corresponding author on reasonable request. ER -